PharmaShots | Incisive News in 3 Shots

Subscribe Now

Sulinno

Innovent's Sulinno (biosimilar- adalimumab) Receives NMPA's Approval for Autoimmune Diseases

Innovent's Sulinno (biosimilar- adalimumab) Receives NMPA's Approval for Autoimmune Diseases

September 4, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us